TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
COLL

Collegium Pharmaceutical Inc

Healthcare · Drug Manufacturers - Specialty & Generic

22.50$ -1.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Collegium Pharmaceutical Inc (COLL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,136 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COLL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,178 1,143 1,114 1,053 1,635 1,664 1,631 1,593 1,607 1,657 1,652 2,136
537 538 539 510 444 482 528 549 614 691 746 608
259 239 229 173 39 71 96 117 170 251 269 129
305 311 318 272 120 163 198 222 306 407 422 129
182 180 175 184 228 229 229 213 234 211 229 285
34 32 31 28 38 36 37 38 38 41 43 113
134 134 134 134 146 162 151 148 146 146 146 190
456 422 387 353 947 891 836 780 725 670 614 1,186
999 948 892 837 1,401 1,435 1,397 1,360 1,333 1,355 1,340 1,824
465 458 446 462 459 510 487 465 453 440 435 590
184 184 184 184 66 66 66 66 66 30 34 57
3.7 8.7 6.0 2.4 3.1 3.9 18 11 7.6 11 6.8 9.2
528 484 440 369 803 788 773 758 744 780 770 1,037
179 195 222 217 234 229 234 232 275 302 312 312
-265 -233 -205 -186 -177 -164 -162 -150 -118 -101 -87 -102
42 42 41 40 40 40 33 39 39 40 40 32

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?